Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR.
Lam PY, Omer N, Wong JKM, Tu C, Alim L, Rossi GR, Victorova M, Tompkins H, Lin CY, Mehdi AM, Choo A, Elliott MR, Coleborn E, Sun J, Mercer T, Vittorio O, Dobson LJ, McLellan AD, Brooks A, Tuong ZK, Cheetham SW, Nicholls W, Souza-Fonseca-Guimaraes F.
Lam PY, et al. Among authors: brooks a.
Clin Transl Med. 2025 Jan;15(1):e70140. doi: 10.1002/ctm2.70140.
Clin Transl Med. 2025.
PMID: 39763064